Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.24.3
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 9 Months Ended 12 Months Ended
Sep. 28, 2024
Dec. 30, 2023
Stock Options    
Beginning balance outstanding (in shares) 719,525  
Granted (in shares) 0  
Exercised (in shares) (2,069)  
Forfeited (in shares) (40,871)  
Ending balance outstanding (in shares) 676,585 719,525
Unvested (in shares) 339,340  
Vested (in shares) 337,245  
Weighted-Average Grant Date Fair Value    
Beginning balance outstanding (in dollars per share) $ 4.5  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 4.5  
Forfeited (in dollars per share) 4.9  
Ending balance outstanding (in dollars per share) 4.5 $ 4.5
Vested (in dollars per share) 4.5  
Weighted-Average Exercise Price, per share    
Beginning balance outstanding (in dollars per share) 9.4  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 9.5  
Forfeited (in dollars per share) 10.0  
Ending balance outstanding (in dollars per share) 9.4 $ 9.4
Vested (in dollars per share) $ 9.4  
Weighted Average Remaining Contractual Life (in years) 7 years 8 months 12 days 8 years 4 months 24 days
Weighted Average Remaining Contractual Life, Exercised (in years) 7 years 8 months 12 days  
Weighted Average Remaining Contractual Life, Forfeited (in years) 8 years  
Weighted Average Remaining Contractual Life, Vested not exercised (in years) 7 years 8 months 12 days  
Aggregate Intrinsic Value $ 0.6 $ 2.6
Aggregate Intrinsic Value, unvested 0.3  
Aggregate Intrinsic Value, Vested not exercised $ 0.3